The Effects of Enoximone in Acute Exacerbation COPD

Clinical trial NCT04420455 · TERMINATED

Trial details

NCT number: NCT04420455
Sponsor: Rijnstate Hospital
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

COPD Exacerbation Enoximone Phosphodiesterase Inhibitor

Start date: 2020-05-12
Primary completion: 2021-12-21
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.